#Neurovascular Devices Market Trend

[industryforecastnews]

Neurovascular Devices Market Size To Reach USD 4.53 Billion By 2030

Neurovascular Devices Market Growth & Trends

The global neurovascular devices market size is anticipated to reach USD 4.53 billion by 2030, registering a CAGR of 6.01% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of neurological illnesses such as stroke, brain aneurysm, and cerebral artery stenosis is driving growth of the neurovascular devices market. According to the World Stroke Organization (WSO), in 2022, there will be more than 12.2 million new strokes per year.

One in every four adults above the age of 25 will suffer a stroke throughout their lifetime. In addition, nearly 7.6 million new ischemic strokes occur each year. Around 62.0% of all incident strokes worldwide are ischemic strokes, with more than 1.2 million new subarachnoid hemorrhages occurring each year. As a result, the figures show that there is a significant demand for the neurovascular devices, which is driving neurovascular device market expansion.

The rising prevalence of brain aneurysms in both developed and developing countries is driving the introduction of technologically advanced products to the market. Some significant therapeutic techniques for an intracranial aneurysm include surgical clipping, endovascular coiling, and flow diverters. Market participants are constantly working to introduce technologically advanced products to the market.

For instance, in September 2021, Medtronic plc. announced the CE Mark clearance of its radial artery access portfolio, which comprises the Rist 079 Access Radial Guide Catheter and the Access Rist Radial Selective Catheter. Furthermore, in March 2022, Micro Port Scientific Company announced that its Hyper flex Balloon Catheter has received registration approval from the Japan Pharmaceuticals and Medical Devices Agency (PMDA).

Reduced postoperative discomfort and faster recovery are the factors expanding use of the minimally invasive operations and fueling R&D in this field. Endovascular coiling is a minimally invasive surgery that is frequently suggested by the clinicians for the treatment of cerebral aneurysms. Hydro Coils (MicroVention, Tustin, California, USA) have permitted the treatment of more complex aneurysmal structures with reduced recurrence rates as compared to bare-platinum coils. As a result, increased demand for the minimally invasive procedures is supporting neurovascular device market expansion.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/neurovascular-devices-market

Neurovascular Devices Market Report Highlights

In 2022, cerebral embolization and aneurysm coiling devices dominated the neurovascular devices market with a market share of 34.79%. As the prevalence of cerebral artery stenosis rises, major players are introducing more technologically advanced products

Based on therapeutic application, stroke segment dominated the market in 2022 with a market share of 57.10% due to the increasing prevalence of stroke, globally. The increasing frequency of strokes around the world has resulted in a significant demand for the management of these cases, necessitating the intensive use of neurovascular devices

Among size, 0.021" held a majority market share of 27.26% in the year 2022. This is due to 0.021” size products are preferred over others owing to superior flow rates and embolic compatibility

Among end use, hospitals held a majority market share of 70.97% in the year 2022. Increasing number of patients being admitted to the hospitals due to the surgeries, therapies, and treatments is expected to favor the neurovascular device market. Thus, subsequent increase in number of patients across the globe, launch of technologically advanced products, and favorable reimbursement policies are leading to a growing demand for the hospital treatments

North America led the market with the maximum revenue share of 26.44% in 2022. Rising demand for the minimally invasive surgeries, and increasing government initiative for improving healthcare infrastructures are among the key factors driving the market growth. In addition, technological advancement and innovation of new noninvasive techniques will create lucrative opportunities for the segment

Regional Insights

North America dominated the neurovascular devices market with the share of 26.44% in 2022 owing to the presence of key manufacturers such as Penumbra, Inc., Stryker Corporation, Johnson & Johnson, and Merit medical systems, Inc. in the region. In February 2023, Phenox Inc. stated that their pRESET Thrombectomy Device has been cleared by the FDA for use in the treatment of acute ischemic stroke. The product pRESET, which has been marketed in Europe for more than  a decade, has now been approved for use in the U.S. Furthermore, rising prevalence of neurological disorders, and increasing demand for the minimally invasive surgical procedures are driving the neurovascular devices market growth in this region.

Neurovascular Devices Market Segmentation

Grand View Research has segmented the global neurovascular devices market based on the device, therapeutic application, size, end use, and regions:

Neurovascular Devices Device Outlook (Revenue USD Million; Volume Unit; 2018 - 2030)

Cerebral Embolization and Aneurysm Coiling Devices

Cerebral Angioplasty and Stenting Systems

Neurothrombectomy Devices

Support Devices

Trans Radial Access Devices

Neurovascular Devices Therapeutic Application Outlook (Revenue USD Million; 2018 - 2030)

Stroke

Cerebral Artery

Cerebral Aneurysm

Others

Neurovascular Devices Size (in Inches) Outlook (Revenue USD Million; 2018 - 2030)

0.027"

0.021"

0.071"

0.017"

0.019"

0.013"

0.058"

0.068"

Others

Neurovascular Devices End Use Outlook (Revenue USD Million; 2018 - 2030)

Hospitals

Specialty Clinics

Others

Neurovascular Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

Europe

Asia Pacific

Latin America

Middle East and Africa (MEA)

List of Key Players In Neurovascular Devices Market

Medtronic

Johnson and Johnson Services Inc.

Penumbra, Inc.

Micro port Scientific Corporation

Stryker

Microvention Inc. (Terumo Corporation)

Codman Neuro (Integra Life sciences)

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/neurovascular-devices-market

[market-spy]

Neurovascular Devices Market to Surpass USD 6.04 Billion by 2031, Witnessing 8.5% CAGR Growth | SkyQuest Technology

SkyQuest projects that the Neurovascular Device Market will attain a value of USD 6.04 Billion by 2031, with a CAGR of 8.5% during the forecast period (2024-2031).  The neurovascular devices market is boosted by the growing prevalence of neurological diseases, technological advancement, and rising demand for minimally invasive processes. In recent times, many people are suffering from neurological diseases like brain aneurysm, strokes, and epilepsy, and this is resulting in a significant rise in demand for neurovascular devices. Another disease contributing to the growth of the market is acute ischemic stroke. The popularity of minimally invasive surgeries is also increasing because of the decreases risk and trauma related to these processes. Postoperative pain can be reduced with smaller incisions leading to speedy recovery. These factors are increasing the adoption of these procedures and prompting the advancement of R&D in the field. In recent times, many companies have started investing in R&D to introduce advanced minimally invasive surgical devices. The endovascular coiling utilized for treating intracranial aneurysm is one of such procedures that is widely used by physicians. These types of procedures to treat diseases are increasing the market growth of neurovascular device market.

Download a detailed overview: https://www.skyquestt.com/sample-request/neurovascular-devices-market

Increasing Adoption of Minimally Invasive Surgeries to Reduce Risks will Boost Growth Rate

in the last few years, an inclination towards minimally invasive surgeries have increased among physicians and also patients, increasing its popularity. The primary reason for this is it has very littles risk associated with it and does not create trauma among patients. Small incisions are required to perform the surgeries, which accelerates the recovery timings. These factors have immensely encouraged doctors to implement these surgery techniques. Companies and government institutions are also investing more to improve research and development in this field to increase advancement. The development of technologies like embolic coils, advanced aspiration catheters, revascularization devices for ischemic strokes are the result of R&D. Such innovative devices have encouraged this shift towards advanced neurovascular devices.

Growing Prevalence of Neurovascular Disorder with Changing Lifestyle to Influence Market Growth

The market for neurovascular devices is primarily driven by the increasing cases of neurovascular diseases like strokes or aneurysms. As per NHS England, almost 1 in 12,500 people in England have ruptured brain aneurysm each year. Moreover, brain aneurysm impacts almost 3.0% of the persons of the U.K. Therefore, this rapidly growing patient population for target diseases in the market is mainly responsible for the high consumption of neurovascular devices, resulting in market growth. Another factor positively influencing the neurovascular devices market is the aging of the global population who are extremely vulnerable to chronic diseases and require surgeries. In the past few years, people have witnessed massive lifestyle changes as it has become more fast-paced and unhealthy eating habits have increased. Such lifestyles bring in a lot of risks like diabetes, obesity, and hypertension that can lead to many targeted diseases, increasing neurovascular issues. These factors support the growth of the market.

Increasing Awareness about Neurological Disorders Promotes Neurovascular Devices North America Boosting Market Growth

North America accounts for the dominant market share of neurovascular devices. This can be attributed to factors like increased awareness of neurological disorders, growing geriatric population, and advanced medical care infrastructure. There are also many key players present in the region creating developmental strategies to boost market growth. The market of the Asia-Pacific region is also growing rapidly due to huge population and increasing expenditure on advanced healthcare systems. Rise in disposable is also positively influencing the market as it is encouraging the adoption of neurovascular devices.

Neurovascular Devices Market Insights

Drivers:

Strategic partnerships among key market players to increase the demand for the neurovascular device with advanced products.

Rising geriatric population to create lucrative opportunities for the market.

Emphasis on patient outcome and quality of life is a major factor contributing to the growth.

Better reimbursement policies are accelerating the demand for neurovascular devices.

Restraints:

Strict regulations are an important factor that is decreasing the viability of the market

High expense of neurovascular processes is restraining the market growth

Very less access to advanced healthcare facilities, especially in developing regions can be a challenge

High risk of complications and adverse events can impede the development of the market

Key Players in Neurovascular Market

Acandis GmbH

Asahi Intecc Co. Ltd.

Imperative Care Inc.

Integer Holdings Corporation

Johnson & Johnson

Medtronic plc

MicroPort Scientific Corporation

Penumbra Inc.

Perflow Medical Ltd.

Rapid Medical

Stryker Corporation

Key Questions Answered in the Neurovascular Market

Which are the key players of the neurovascular Market?

What are the critical drivers of the market?

Which region is leading the neurovascular market?

What is neurovascular market growth?

This report provides the following insights:

Analysis of key drivers (Strategic collaboration among companies, rising geriatric population, Emphasis on patient outcome and quality of life, and Better reimbursement), restraints (Integration with existing system and High expense), opportunities (Surging incidences of neurovascular diseases, Increasing technological advancement, High demand for minimally invasive procedures, and Rising awareness), and challenges (Stringent regulations, Restricted access to advanced healthcare, and High risk of complications) influencing the growth of neurovascular devices market

Market Penetration: Comprehensive information on the product offered by the top players in the neurovascular devices market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the neurovascular devices market

Market Development: Comprehensive information on emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology. 

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.

Contact:

Mr. Jagraj Singh

SkyQuest Technology

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 351-333-4748

Email: sales@skyquestt.com

Visit Our Website: https://www.skyquestt.com/

[health-views-updates]

Neurovascular Devices Market Future Outlook: Predictions and Analysis

Neurovascular Devices Market Outlook, Scope & Overview:

Industry reports indicate that the global neurovascular devices market was valued at USD 3.01 billion in 2023 and is projected to reach USD 4.81 billion by 2030, growing at a CAGR of 6.05% over the forecast period 2024-2031.

Technological Advancements to Drive Growth of Global Neurovascular Devices Market

The adoption of advanced neurovascular devices will continue to influence global market revenues. Healthcare providers are increasingly utilizing neurovascular devices due to their effectiveness in treating various cerebrovascular conditions, including aneurysms, arteriovenous malformations, and strokes.

As a product segment, embolization devices currently hold a significant share of the global neurovascular devices market. This segment is anticipated to grow at a year-over-year rate of 6.05% in 2024 over 2023 and reach USD 4.81 billion in revenues by 2030. The increasing prevalence of neurovascular diseases, coupled with advancements in minimally invasive surgical techniques, is expected to drive market growth.

Neurovascular Devices – Market Dynamics

Drivers:

Neurovascular devices are witnessing significant growth in the global market due to their ability to provide effective treatment for cerebrovascular conditions. The demand for minimally invasive procedures, the growing prevalence of neurological disorders, and the increasing geriatric population are key factors driving the adoption of neurovascular devices worldwide. Additionally, technological advancements and the development of novel devices are further propelling market growth.

Restraints:

Despite the growth potential, challenges such as high costs of neurovascular devices, the complexity of procedures, and the need for skilled healthcare professionals are hindering the widespread adoption of these devices. Moreover, stringent regulatory requirements and the risk of complications associated with neurovascular procedures pose additional challenges to market expansion.

Neurovascular Devices – Market Outlook

The proven benefits of neurovascular devices in treating cerebrovascular conditions and improving patient outcomes have contributed to the market's growth. Neurovascular devices are expected to witness increased adoption across major healthcare markets, including North America, Europe, and Asia Pacific, driven by advancements in technology and the increasing focus on improving neurovascular care.

Global Neurovascular Devices Market

The rise in demand for neurovascular devices in developed and emerging markets is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global neurovascular devices market, with the US being a key contributor to market revenues. Europe and Asia Pacific regions are also experiencing rapid adoption of neurovascular devices, supported by favorable regulatory frameworks and increasing investments in healthcare infrastructure.

Key Players in the Neurovascular Devices Market

Leading companies in the neurovascular devices market include Medtronic plc, Stryker Corporation, Johnson & Johnson, and Terumo Corporation. These companies are at the forefront of developing and commercializing advanced neurovascular devices for various applications, including aneurysm repair, stroke management, and arteriovenous malformation treatment.

In conclusion, the global neurovascular devices market is poised for substantial growth over the forecast period, driven by technological advancements, increasing prevalence of neurovascular diseases, and the expanding adoption of minimally invasive procedures across diverse healthcare settings.

Other Trending Reports

Neuroprosthetics Industry Trends

Hospital Capacity Management Solutions Industry Trends

3D Printing Medical Devices Industry Trends

Blockchain Technology in Healthcare Industry Trends

[insightfulblogz]

Microcatheters Market Trends, Growth, Top Companies, Revenue, and Forecast to 2032

Microcatheters are advanced medical devices designed for navigating small and complex vascular systems, particularly in minimally invasive procedures. These slender catheters, usually less than 3 French in diameter, offer high precision and control, making them essential in fields such as interventional cardiology, neurology, and oncology. By enabling targeted drug delivery and assisting in complex surgical navigation, microcatheters play a critical role in enhancing patient outcomes and reducing procedural complications. Their flexibility and maneuverability make them ideal for accessing difficult-to-reach areas within the body with minimal disruption to surrounding tissues.

The Microcatheters Market Size was valued at USD 1.98 billion in 2022, and is expected to reach USD 2.71 billion by 2030 and grow at a CAGR of 4% over the forecast period 2023-2030.

Future Scope

The future of microcatheters is promising, with ongoing advancements focusing on improved materials, flexibility, and biocompatibility. Innovations such as steerable microcatheters and drug-coated options are expected to enhance procedural precision and therapeutic efficacy. As demand grows for minimally invasive interventions, the development of smaller, more versatile microcatheters that can perform multiple functions will drive growth. These devices are likely to become increasingly specialized for various procedures, particularly as interventional radiology and endovascular treatments continue to evolve.

Trends

Recent trends in microcatheter development include the incorporation of hydrophilic coatings for enhanced maneuverability and the use of high-strength yet flexible materials, such as nitinol and polymer composites. The trend toward single-use, disposable microcatheters is also rising, driven by the need for enhanced sterility and reduced infection risk. Furthermore, integration with imaging systems and robotic guidance is becoming more common, providing real-time navigation that improves procedural accuracy and outcomes.

Applications

Microcatheters are used in diverse applications, including coronary interventions, neurovascular procedures like aneurysm coiling, and cancer therapies that require localized drug delivery. They are also employed in peripheral vascular interventions, embolization, and tissue sampling. Due to their ability to navigate small and delicate vessels, microcatheters are critical in procedures that require precision, such as tumor embolization and complex cardiovascular interventions.

Key Points

Microcatheters provide high precision in minimally invasive procedures across various specialties.

Future advancements focus on improved materials, flexibility, and specialized functionality.

Trends include hydrophilic coatings, high-strength materials, and single-use designs.

Widely applied in cardiology, neurology, oncology, and vascular interventions.

Integration with imaging and robotic systems is enhancing procedural accuracy and outcomes.

Conclusion

Microcatheters are redefining the standards of minimally invasive medicine, allowing for greater precision, safety, and efficacy in a range of complex procedures. As technology advances, these devices will continue to play an essential role in expanding the possibilities of interventional medicine. The evolution of microcatheters is expected to contribute significantly to improved patient care, providing a critical tool for clinicians to perform intricate interventions with higher accuracy and patient safety.

[trendtrackershq]

How Are Recent Innovations Shaping the Future of the Neurovascular Device Market?

Introduction:

The Neurovascular Device Market is undergoing a significant transformation driven by a series of recent innovations and breakthroughs. As the field of neurovascular intervention continues to evolve, these developments are poised to enhance patient outcomes and redefine treatment standards. This article explores how the latest advancements are shaping the future of the neurovascular device market, providing insights into the cutting-edge technologies and trends influencing the industry.

Download FREE Sample: https://www.nextmsc.com/neurovascular-device-market/request-sample

1. What Are the Latest Innovations in Neurovascular Devices?

Recent innovations in neurovascular devices are pushing the boundaries of what is possible in the treatment of cerebrovascular conditions. Key advancements include:

1.1. Advanced Stent Technologies

The development of next-generation neurovascular stents represents a significant leap forward. Companies like Medtronic and Stryker have introduced stents with improved delivery systems and enhanced biocompatibility. For instance, the Medtronic Solitaire X stent retriever has been designed to offer superior clot removal capabilities with a more precise deployment mechanism, leading to better clinical outcomes in thrombectomy procedures.

1.2. Bioresorbable Devices

Bioresorbable devices are gaining traction as a promising innovation. Unlike traditional metal stents, bioresorbable stents gradually dissolve over time, leaving behind a restored blood vessel without a permanent implant. Abbott’s Absorb BVS, though discontinued, has set a precedent for future developments in this area, highlighting the potential for bioresorbable materials to improve long-term patient outcomes.

1.3. Next-Generation Coiling Systems

Advancements in endovascular coiling systems are improving the treatment of cerebral aneurysms. Newer coiling systems, such as those developed by Penumbra, offer enhanced stability and control during deployment, which helps in better aneurysm occlusion and reduces the risk of recanalization.

2. How Are Regulatory Approvals Impacting the Market?

Regulatory approvals are crucial in determining the success of new neurovascular devices. Recent approvals and clearances have had a significant impact on the market, facilitating the introduction of innovative products.

2.1. FDA Approvals

The U.S. Food and Drug Administration (FDA) has recently approved several new neurovascular devices, including:

Cerenovus’ PulseRider: A novel device designed to treat complex intracranial aneurysms by providing a scaffold for coiling. Its approval marks a significant advancement in the management of challenging aneurysm cases.

Inari Medical’s ClotTriever: This device, designed for mechanical thrombectomy, has received FDA clearance for its effectiveness in removing large clots from deep veins, demonstrating its potential for broader applications beyond stroke treatment.

2.2. European CE Markings

In Europe, the CE Marking has been granted to several new neurovascular devices, including the Stryker Surpass Streamline stent. This approval allows for the commercialization of these devices across European markets and contributes to the global expansion of neurovascular treatment options.

3. What Role Do Emerging Markets Play in the Neurovascular Device Industry?

Emerging markets are becoming increasingly important in the neurovascular device industry. The growing healthcare infrastructure and rising prevalence of neurovascular disorders in these regions are driving market expansion.

3.1. Market Growth in Asia-Pacific

Countries in the Asia-Pacific region, such as China and India, are experiencing rapid growth in healthcare spending and infrastructure development. This growth is facilitating the adoption of advanced neurovascular devices. For example, the introduction of minimally invasive neurovascular technologies in these markets is improving treatment accessibility and driving market demand.

3.2. Expansion in Latin America and the Middle East

Similarly, Latin America and the Middle East are witnessing increased investment in healthcare infrastructure and a growing focus on advanced medical technologies. The rise in neurovascular conditions in these regions is prompting healthcare providers to seek innovative solutions, boosting the market for neurovascular devices.

4. How Is the Focus on Minimally Invasive Procedures Affecting Device Development?

The shift towards minimally invasive procedures is a major trend influencing the neurovascular device market. This focus is driving the development of new devices and techniques aimed at reducing patient recovery times and improving procedural outcomes.

4.1. Enhanced Catheter Technologies

Recent advancements in catheter technologies are enabling more precise and controlled interventions. Innovations such as the Penumbra 3D Revascularization Device are designed to enhance clot retrieval and reduce procedure-related complications.

4.2. New Imaging Techniques

The integration of advanced imaging techniques, such as 3D rotational angiography and intravascular ultrasound, is improving the accuracy of neurovascular interventions. These techniques provide detailed visualization of blood vessels, allowing for better planning and execution of procedures.

5. What Impact Do Strategic Collaborations Have on the Market?

Strategic collaborations between medical device companies, research institutions, and healthcare providers are playing a crucial role in advancing neurovascular device technology.

5.1. Industry Partnerships

Partnerships between companies like Medtronic and Boston Scientific are driving innovation through joint R&D efforts. These collaborations enable the sharing of expertise and resources, leading to the development of cutting-edge neurovascular devices and technologies.

5.2. Academic and Research Collaborations

Collaborations with academic institutions and research organizations are also contributing to the advancement of neurovascular devices. For instance, partnerships with institutions such as the Cleveland Clinic are facilitating clinical trials and research studies that support the development and validation of new devices.

6. How Are Patient-Centered Approaches Influencing Device Design?

Patient-centered approaches are increasingly influencing the design and development of neurovascular devices. The focus is shifting towards creating devices that not only improve clinical outcomes but also enhance the overall patient experience.

6.1. User-Friendly Designs

Design improvements aimed at enhancing ease of use and patient comfort are becoming more common. For example, new devices are being designed with features that simplify deployment and reduce procedural complexity, benefiting both patients and healthcare providers.

6.2. Personalized Treatment Options

Advancements in personalized medicine are influencing the development of customized neurovascular devices. Personalized treatment approaches are being integrated into device design to cater to the specific needs of individual patients, improving treatment efficacy and safety.

Conclusion

The neurovascular device market is rapidly evolving, driven by recent innovations, regulatory approvals, and emerging market opportunities. Advances in device technology, a focus on minimally invasive procedures, and strategic collaborations are shaping the future of neurovascular interventions. As the industry continues to grow and innovate, these developments are expected to enhance patient outcomes and redefine treatment standards in neurovascular care.

For stakeholders in the neurovascular device industry, staying abreast of these trends and innovations is crucial for navigating the competitive landscape and capitalizing on emerging opportunities.

[creativeera]

The Rising Global Demand for Minimally Invasive Procedures will drive the Blood Clot Retrieval Devices Market

The blood clot retrieval devices market is a niche but rapidly growing segment due to the increasing preference for minimally invasive procedures for treating conditions such as cardiovascular diseases and neurological disorders. Blood clot retrieval devices are used to remove blood clots from arteries or veins, usually during acute ischemic stroke. They help restore blood flow and limit neurological damage. Key devices available include stent retrievers, aspiration devices, vascular snares, and clot-busting drugs.

The global blood clot retrieval devices market is estimated to be valued at USD 1.62 Bn in 2024 and is expected to reach USD 4.40 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 15.3% from 2024 to 2031.

Key Takeaways    Key players operating in the blood clot retrieval devices are Stryker Corporation, Medtronic plc, Johnson & Johnson, Boston Scientific Corporation, Penumbra, Inc., Terumo Corporation, Edwards Lifesciences Corporation, Argon Medical Devices, Inc., Cook Medical Inc., Control Medical Technology, Acandis GmbH, Phenox GmbH, B. Braun Melsungen AG, Teleflex Incorporated, MicroVention, Inc., Merit Medical Systems, W. L. Gore & Associates, Inc., and Inari Medical, Inc. Stent retrievers are increasingly being used for mechanical thrombectomy to remove large blood clots from arteries during acute ischemic stroke. Aspiration catheters are also growing in popularity due to their ease of use.    The increasing global disease burden of strokes and cardiac arrests is a major driver of demand for Blood Clot Retrieval Devices Market Demand . According to WHO, over 15 million people suffer a stroke each year worldwide. Rising awareness about minimally invasive procedures and availability of advanced devices are supporting the adoption of mechanical thrombectomy for time-critical conditions. Technology advancements such as bioabsorbable polymers, self-expanding stent designs and optimized catheter structures are helping improve outcomes.    Key trends in the market include the introduction of newer generation stent retrievers and aspiration catheters with enhanced efficacy. Companies are focusing on developing innovative retrieval techniques as well as devices compatible with imaging modalities like CT and MRI. Wider access todevices aided by favorable reimbursement and regulatory approvals will further support market growth. Expanding applications from neurovascular to peripheral vascular procedures present new opportunities.   The main opportunities in the Blood Clot Retrieval Devices Market Analysis raising awareness in developing regions, launch of low-cost devices, and utilization of latest materials and automation technologies for better clot removal success rates. Emerging economies with large patient populations but low treatment rates offer scope for market penetration. With ongoing R&D, retrieval devices may replace conventional open surgeries over the long run.    The COVID-19 pandemic has significantly impacted the growth of the blood clot retrieval devices market. The spread of the virus and subsequent lockdowns enforced globally led to postponement of elective surgeries, negatively impacting the market in the initial months. Elective procedures such as neurointerventional procedures were delayed to focus resources on managing COVID-19 patients.  

Get more insights on Blood Clot Retrieval Devices Market

[healthcaremarketanalysis]

X-Ray Detectors Market Size, Share, Trends and Revenue Forecast [2029]

The global X-Ray Detectors market in terms of revenue was estimated to be worth $3.1 billion in 2023 and is poised to reach $4.2 billion by 2029, growing at a CAGR of 5.0% from 2023 to 2029. 

Download an Illustrative overview:

X-Ray Detectors Market: Market Dynamics

Driver: Investment to advance healthcare facilities & digital imaging Technologies.

X-Ray detectors play a crucial role in facilitating the work of healthcare professionals in diagnosing and treating patients. The efficient utilization of cutting-edge equipment, like X-ray detectors, enables the screening of a greater number of patients at reduced expenses and with significant time savings. Increased support, funding, and investments are expected to substantially enhance the accessibility and adoption of these technologies, contributing to the continued growth of the market.

Restraint: High cost of X-ray detectors

The X-ray detector market faces limitations due to the high cost associated with these devices. Beyond being a constraint, this factor poses a challenge for economically disadvantaged and developing nations seeking to embrace new technologies. Insufficient funding in many hospitals further hinders the possibility of acquiring these modern technologies. As countries globally aim to advance and integrate state-of-the-art technologies, manual security checks are becoming obsolete. However, the concern of health hazards arises, particularly in security applications, as these detectors have demonstrated a potential link to cancer, presenting a genuine limitation. Additionally, addressing the shortage of qualified radiologists is another pressing issue that needs attention.

Opportunity: Rising healthcare expenditure across developing countries

Within the X-ray detector market, there are promising opportunities in emerging regions like the Asia-Pacific (APAC) and India. These countries are experiencing substantial growth in medical tourism, fueled by factors such as population expansion, increasing sedentary lifestyles, and the rapid development of medical tourism infrastructure. These elements are driving an uptick in health issues like cardiovascular and neurovascular diseases. Furthermore, these nations boast above-average returns on investments and are recognized for having a skilled labor force. Government initiatives and policies are actively fostering the development and expansion of the medical tourism industries in these countries.

Challenge: Lack of animal awareness in emerging and developing countries

The X-ray detector market faces ongoing challenges from global competitors, with Chinese players holding significant influence. Moreover, the expenditure on animal health in developing nations, such as India, China, and Africa, is notably limited when compared to industrialized countries like North America. Additionally, these growing nations lack a well-established understanding of animal health, prioritizing therapeutic medical treatments over procedures involving X-ray detectors.

By region, North America is expected to be the largest market in the x-ray detectors industry during the forecast period.

North America, comprising the US and Canada, accounted for the largest share of the X-ray detectors market in 2022. The growth of the X-ray detector market in North America is propelled by several factors, including the rising number of target diagnostic and interventional procedures conducted in the region, a high prevalence of diseases, an increasing geriatric population, and the widespread availability of advanced interventional products, including microcatheters.

As of 2022, prominent players in the X-ray detectors market are Varex Imaging Corporation(US), Thales Group ( France), Canon ( Japan), Fujifilm Corporation (Japan), Agfa-Gevaert Group (Belgium) and Teledyne Technologies(US), and among others.

Recent Developments of X-Ray Detectors Industry:

In May 2023, Varex Imaging Corporation launched the XRD 3131N digital X-ray detector to cater to the rising demand for expedited and more extensive inspections within the rapidly evolving Electric Vehicle (EV) battery manufacturing sector. This enhances the company's existing portfolio for the EV battery inspection market.

In July 2022, Canon Inc. launched the CXDI-Elite series of wireless digital radiography (DR2) devices, including the CXDI-720C Wireless sensor unit, to markets outside of Japan. These devices aim to enhance user-friendliness across various imaging scenarios while delivering superior image quality to facilitate more accurate diagnostics.

March 2021, At ECF 2021, the Thales unveiled the Pixium 3040F, featuring enhanced image quality, optimized spatial resolution, increased contrast, and superior sensitivity at lower radiation doses.

Frequently Asked Questions (FAQ):

1) What is the projected market revenue value of the global X-Ray Detectors Market?

The global X-Ray Detectors market boasts a total revenue value of $4.2 billion by 2029.

2) What is the estimated growth rate (CAGR) of the global X-Ray Detectors Market?

The global X-Ray Detectors market has an estimated compound annual growth rate (CAGR) of 5.0% and a revenue size in the region of $3.1 billion in 2023. 

Request Sample Pages:

[delveinsight12]

Anterior Uveitis Market: Trends, Challenges, and Opportunities for Growth

Anterior uveitis is an inflammatory condition that affects the front part of the eye, specifically the iris and ciliary body. It is also known as iritis and is one of the most common forms of uveitis. Anterior uveitis can be a serious condition that, if left untreated, can lead to permanent vision loss. In this blog, we will discuss the symptoms, treatment, and the current market and pipeline for anterior uveitis.

Anterior Uveitis Symptoms

The symptoms of anterior uveitis can be mild or severe and may include redness, pain, light sensitivity, blurred vision, and floaters. It can affect one or both eyes and can occur suddenly or develop over several days. It is important to seek medical attention if you experience any of these symptoms, as untreated anterior uveitis can lead to complications such as glaucoma, cataracts, and permanent vision loss.

Anterior Uveitis Treatment

The treatment for anterior uveitis depends on the severity of the condition. In mild cases, over-the-counter pain relievers and eye drops may be sufficient. In more severe cases, steroid eye drops or injections may be necessary to reduce inflammation. It is important to work closely with an ophthalmologist to determine the most appropriate treatment for your specific case.

Download a sample Anterior Uveitis market report @ https://www.delveinsight.com/sample-request/anterior-uveitis-market

Anterior Uveitis Drugs and Therapies

There are currently several drugs and therapies in development for the treatment of anterior uveitis. These include topical and systemic corticosteroids, immunosuppressive agents, and biologic therapies. The goal of these treatments is to reduce inflammation and prevent complications associated with the condition. The anterior uveitis market is expected to grow in the coming years, driven by the development of new therapies and an increasing prevalence of the condition.

Anterior Uveitis Pipeline

The anterior uveitis pipeline is robust, with several promising drugs and therapies in various stages of development. One of the most promising therapies is a biologic agent that targets the interleukin-6 (IL-6) receptor, which plays a key role in the inflammatory process. Another therapy in development is a small molecule inhibitor of the Janus kinase (JAK) pathway, which is involved in the immune response.

In conclusion, anterior uveitis is a serious condition that can lead to permanent vision loss if left untreated. The symptoms of anterior uveitis include redness, pain, light sensitivity, blurred vision, and floaters. Treatment depends on the severity of the condition and may include over-the-counter pain relievers, steroid eye drops or injections, or other drugs and therapies. The anterior uveitis market is expected to grow, driven by the development of new therapies and an increasing prevalence of the condition. The pipeline for anterior uveitis is promising, with several drugs and therapies in development that target the underlying inflammatory process. If you experience any symptoms of anterior uveitis, it is important to seek medical attention promptly to prevent complications and preserve your vision.

Request for sample report: https://www.delveinsight.com/sample-request/anterior-uveitis-market

Trending Reports:

Concussions Market Size | Pruritus Market | Angioedema Market | Blood Gas And Electrolyte Analyzers Market | Human Papilomavirus Market | Neurovascular Devices Market | Pain Management Devices Market | Pressure Ulcers Market Size | Acute Coronary Syndrome Market | Apheresis Market | Arteriotomy Closure Devices Market | Automated External Defibrillators Market | Xerostomia Market | Choroidal Neovascularization Market | Hyperhidrosis Market | Alopecia Market | Contraceptive Devices Market | Ventilator Market | Alopecia Aerata Market | Osteoarthritis Market | Neurostimulation Devices Market | Global Electrophysiology Devices Market | Astigmatism Market | Graves Orbitopathy Market | HPV-Induced Cancers Market | Hypothalamic Obesity Market | Italy healthcare outlook report

[health-views-updates]

Neurovascular Devices Market Predictions: Expert Insights on What's Next

The global neurovascular devices market revenue is set for steady growth, with a projected compound annual growth rate (CAGR) of 6.05% from 2024 to 2031. Valued at USD 3.01 billion in 2023, the market is expected to reach USD 4.81 billion by 2030. This growth highlights the increasing demand for innovative treatments and devices aimed at managing neurovascular diseases, such as strokes, aneurysms, and arteriovenous malformations.

Neurovascular devices are used to treat a variety of conditions affecting the blood vessels in the brain and central nervous system. These devices include stents, embolization coils, catheters, flow diverters, and clot retrieval devices. The market growth is driven by advancements in minimally invasive procedures, the increasing prevalence of neurovascular diseases, and the aging global population.

Key Market Drivers

Rising Prevalence of Neurovascular Diseases: Stroke, cerebral aneurysms, and other neurovascular disorders are becoming increasingly common worldwide. Stroke is a leading cause of death and long-term disability, creating a growing need for effective treatments. As the global population ages, the incidence of neurovascular conditions is expected to rise, driving demand for advanced treatment options.

Technological Advancements in Neurovascular Devices: Advances in neurovascular devices, particularly in minimally invasive procedures, are significantly contributing to market growth. Innovations such as next-generation stent retrievers, embolization coils, and flow diverters are providing better outcomes for patients by reducing recovery times and minimizing complications. These advancements have also improved the effectiveness of procedures for both ischemic and hemorrhagic strokes, further driving adoption.

Growing Awareness and Adoption of Minimally Invasive Surgeries: Minimally invasive surgeries are gaining traction as they offer several advantages over traditional open surgeries, including reduced hospital stays, quicker recovery times, and fewer complications. This trend is particularly relevant in the treatment of neurovascular diseases, where minimally invasive procedures, such as mechanical thrombectomy for stroke, are becoming the standard of care. The growing preference for these procedures is driving the demand for neurovascular devices.

Increasing Healthcare Expenditure and Infrastructure: Governments and healthcare organizations are investing heavily in the development of healthcare infrastructure, particularly in emerging markets. This has led to increased access to advanced medical technologies, including neurovascular devices. Coupled with rising healthcare expenditure, this trend is expected to fuel market growth over the forecast period.

Get Free Sample Report: https://www.snsinsider.com/sample-request/1781

Challenges and Opportunities

While the neurovascular devices market is set for growth, several challenges remain. High device costs, along with the complex nature of neurovascular procedures, can limit access, particularly in developing regions. Additionally, the stringent regulatory landscape for medical devices can create barriers to market entry for smaller companies and delay the introduction of new products.

However, these challenges present opportunities for innovation. Companies are investing in the development of cost-effective, user-friendly devices that can expand access to advanced neurovascular treatments. Moreover, increasing research into neurovascular diseases and their treatment options is expected to lead to the development of new, more effective devices.

Regional Insights

North America currently holds the largest share of the neurovascular devices market, driven by the high prevalence of neurovascular disorders, advanced healthcare infrastructure, and robust research and development activities. Europe follows closely, with significant investments in healthcare and medical device technologies.

The Asia-Pacific region is expected to witness the highest growth over the forecast period. Rising healthcare expenditure, improving healthcare infrastructure, and increasing awareness of neurovascular diseases in countries such as China, Japan, and India are key factors driving growth in this region. Additionally, government initiatives to promote medical device manufacturing and innovation in the region are expected to support market expansion.

Future Outlook

The neurovascular devices market is poised for sustained growth over the next decade. With a projected CAGR of 6.05% from 2024 to 2031, the market is expected to reach USD 4.81 billion by 2030. Factors such as technological advancements, the growing prevalence of neurovascular diseases, and increasing adoption of minimally invasive procedures will continue to drive demand for neurovascular devices.

As healthcare providers and governments increasingly focus on improving outcomes for patients with neurovascular conditions, the market is likely to see further innovation and growth. The ongoing development of advanced devices and expanding access to neurovascular treatments in emerging markets will be critical to shaping the future of the industry.

Other Trending Reports

Heart Failure POC & LOC Devices Market

Protein Engineering Market

Alzheimer's Therapeutics Market

Protein Labeling Market

[priyanshisingh]

Intracranial Stents Market Analysis: Global Industry Trends and Forecast (2023-2032)

The global demand for intracranial stents was valued at USD 2358.90 million in 2023 and is expected to reach USD 3951.60 million in 2032, growing at a CAGR of 5.90% between 2024 and 2032.

The Intracranial Stents Market is witnessing substantial growth driven by the rising prevalence of cerebrovascular diseases, increasing awareness about advanced treatment options, and technological advancements in medical devices. Intracranial stents, used to treat conditions such as intracranial stenosis and brain aneurysms, play a crucial role in improving patient outcomes by providing structural support to weakened or narrowed blood vessels in the brain. The growing incidence of stroke and other neurovascular disorders, particularly among the aging population, is a major factor propelling the demand for intracranial stents.

Healthcare professionals are increasingly adopting these stents due to their efficacy in preventing recurrent strokes and reducing the risk of brain hemorrhage. Technological advancements have led to the development of innovative stent designs, such as flow-diverting stents and self-expanding stents, which offer enhanced safety and effectiveness. These advancements are also driving the adoption of minimally invasive procedures, which are associated with shorter recovery times, reduced hospital stays, and lower overall healthcare costs.

The market is characterized by the presence of several key players, including Medtronic, Stryker, and MicroPort Scientific Corporation, who are continually investing in research and development to introduce new products and expand their market presence. Regulatory approvals and favorable reimbursement policies in various regions are also supporting market growth. Additionally, increasing healthcare expenditure, improving healthcare infrastructure, and growing awareness about early diagnosis and treatment of cerebrovascular diseases are contributing to market expansion.

The Intracranial Stents Market is propelled by several key drivers, contributing to its robust growth trajectory. Here are the primary factors driving the market:

Rising Prevalence of Cerebrovascular Diseases: The increasing incidence of cerebrovascular conditions, such as stroke, brain aneurysms, and intracranial stenosis, is a significant driver. As the global population ages, the prevalence of these conditions is expected to rise, boosting the demand for effective treatment options like intracranial stents.

Technological Advancements: Continuous innovation in stent technology has led to the development of advanced intracranial stents that offer improved safety, efficacy, and ease of use. Innovations such as flow-diverting stents, self-expanding stents, and stents with better biocompatibility are enhancing patient outcomes and driving market adoption.

Growing Adoption of Minimally Invasive Procedures: The shift towards minimally invasive surgical procedures is a major driver in the market. Intracranial stents are integral to these procedures, which are preferred due to their benefits, including shorter recovery times, reduced hospital stays, lower risk of complications, and overall cost-effectiveness.

Increasing Awareness and Early Diagnosis: Greater awareness of cerebrovascular diseases and the importance of early diagnosis and intervention are contributing to market growth. Public health initiatives and educational campaigns are helping to identify at-risk populations and promote timely treatment, increasing the demand for intracranial stents.

Improved Healthcare Infrastructure: Advances in healthcare infrastructure, particularly in emerging economies, are facilitating better access to advanced medical treatments. Investments in healthcare facilities and the availability of skilled healthcare professionals are supporting the broader adoption of intracranial stent procedures.

Favorable Reimbursement Policies: In many regions, favorable reimbursement policies for cerebrovascular treatments, including stent implantation, are making these procedures more accessible to patients. This financial support is encouraging more patients to opt for stent-based treatments, thereby driving market growth.

Rising Healthcare Expenditure: Increased healthcare spending by governments and private entities is contributing to the expansion of the intracranial stents market. Higher expenditure allows for the procurement of advanced medical devices and technologies, facilitating the adoption of intracranial stents.

Strategic Collaborations and Product Launches: Leading market players are engaging in strategic collaborations, partnerships, and frequent product launches to expand their market presence and enhance their product portfolios. These activities are driving competition and innovation in the market, benefiting overall growth.

Regulatory Approvals and Clinical Evidence: Obtaining regulatory approvals for new stent designs and accumulating robust clinical evidence of their effectiveness and safety are crucial drivers. These factors enhance the credibility and acceptance of intracranial stents among healthcare providers and patients.

Focus on Preventive Healthcare: An increasing focus on preventive healthcare, particularly for at-risk populations, is driving the demand for intracranial stents. Preventive measures and early interventions can significantly reduce the burden of cerebrovascular diseases, promoting the use of stent-based treatments.

Key Players:

Acandis GmbH

Abbott Laboratories

Medtronic plc

Stryker Corporation

MicroPort Scientific Corporation

DePuy Synthes Companies

Boston Scientific Corporation

Penumbra, Inc.

Balt Extrusion

More About Report- https://www.credenceresearch.com/report/intracranial-stents-market

The Intracranial Stents Market exhibits varied growth patterns and opportunities across different regions, influenced by factors such as healthcare infrastructure, prevalence of cerebrovascular diseases, and regulatory environments. Here’s a detailed regional insight into the market:

North America

United States and Canada

Market Leadership: North America, particularly the United States, holds a significant share of the intracranial stents market. This is attributed to the advanced healthcare infrastructure, high prevalence of cerebrovascular diseases, and early adoption of innovative medical technologies.

Technological Advancements: The presence of leading market players and robust R&D activities drive technological advancements in intracranial stents.

Healthcare Expenditure: High healthcare expenditure and favorable reimbursement policies support market growth.

Awareness and Diagnosis: Greater awareness about cerebrovascular conditions and strong emphasis on early diagnosis and treatment contribute to the high adoption rate of intracranial stents.

Europe

Germany, France, United Kingdom, Italy, Spain

Healthcare Infrastructure: Europe boasts a well-established healthcare system, facilitating the adoption of advanced medical devices.

Regulatory Environment: Stringent regulatory standards ensure the safety and efficacy of intracranial stents, fostering trust among healthcare providers and patients.

Aging Population: The aging population in Europe increases the prevalence of stroke and other cerebrovascular diseases, driving demand for intracranial stents.

Innovative Solutions: European countries are active in clinical research and innovation, contributing to the development and uptake of new stent technologies.

Asia-Pacific

China, Japan, India, Australia, South Korea

Emerging Markets: The Asia-Pacific region is experiencing rapid market growth due to improving healthcare infrastructure and increasing healthcare expenditure.

Growing Awareness: Rising awareness about cerebrovascular diseases and the benefits of early intervention are driving the adoption of intracranial stents.

Technological Integration: Countries like Japan and South Korea are at the forefront of integrating advanced medical technologies, boosting the market.

Economic Growth: Economic growth in countries such as China and India is enabling better access to healthcare services and advanced treatments, contributing to market expansion.

Latin America

Brazil, Mexico, Argentina

Developing Healthcare Systems: The healthcare systems in Latin American countries are developing, with increasing investments in healthcare infrastructure and technology.

Prevalence of Diseases: The prevalence of cerebrovascular diseases is rising, driving the demand for effective treatment options like intracranial stents.

Government Initiatives: Government initiatives to improve healthcare access and quality are supporting market growth.

Medical Tourism: Brazil and Mexico are emerging as hubs for medical tourism, offering advanced treatments at competitive prices, further driving the market.

Middle East and Africa

GCC Countries, South Africa, Egypt

Healthcare Improvements: Significant improvements in healthcare infrastructure and increasing government investments are driving market growth.

Prevalence of Non-communicable Diseases: The rising prevalence of non-communicable diseases, including cerebrovascular conditions, is boosting the demand for intracranial stents.

Regional Disparities: While countries in the GCC region have advanced healthcare systems, other parts of Africa face challenges such as limited access to healthcare and lower adoption of advanced medical technologies.

Market Potential: There is significant market potential in this region as healthcare systems continue to develop and access to advanced treatments improves.

Segmentation:

By Type of Stents

Self-Expanding Stents

Balloon-Expandable Stents

By Material Composition

Metallic Stents

Polymer-Based Stents

By Application

Ischemic Stroke

Intracranial Aneurysms

Intracranial Stenosis

By End User

Hospitals & Clinics

Ambulatory Surgical Centers (ASCs)

Browse the full report –  https://www.credenceresearch.com/report/intracranial-stents-market

Browse Our Blog: https://www.linkedin.com/pulse/intracranial-stents-market-outlook-ngi8f

Contact Us:

Phone: +91 6232 49 3207

Email: sales@credenceresearch.com

Website: https://www.credenceresearch.com